Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Nury Yim

Orthopaedic Surgery Bridgewater, NJ Medical Doctor

NPI 1689052458 CMS profile 11396793

1125 Route 22 Ste 150, Bridgewater, NJ 08807

Open in the dashboard

General payments

$704

21 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nury Yim of Bridgewater, NJ is reported in the CMS Open Payments database as having received $704 across 21 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 25th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $477 13
2024 General $166 5
2023 General $34 2
2022 General $27 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nury Yim
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Nury Yim were reported at $477. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Nury Yim Orthopaedic Surgery median Middle half National median
2019 $0 $644 $140–$2,844 $163
2020 $0 $312 $75–$1,860 $114
2021 $0 $520 $117–$2,495 $132
2022 $27 $598 $128–$2,731 $149
2023 $34 $461 $128–$2,264 $160
2024 $166 $497 $134–$2,475 $164
2025 $477 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Stryker Corporation $198 3 payments
  2. Endo USA, Inc. $146 1 payment
  3. DePuy Synthes Sales Inc. $79 4 payments
  4. Ferring Pharmaceuticals Inc. $60 3 payments
  5. Zimmer Biomet Holdings, Inc. $50 1 payment
  6. Smith+Nephew, Inc. $47 2 payments
  7. Vertex Pharmaceuticals Incorporated $32 2 payments
  8. Dynasplint Systems Inc. $22 1 payment
  9. Bioventus LLC $20 1 payment
  10. SeaPearl Inc $19 1 payment
  11. Other $30 2 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $704 21 payments
Products named General payments · program years 2022–2025
  1. XIAFLEX $160 2 payments
  2. CONEXTIONS TR TENDON REPAIR SYSTEM-IMPLANT MECHANISM $118 1 payment
  3. ORTHOVISC $79 4 payments
  4. MONOVISC $63 3 payments
  5. VARIAX $60 1 payment
  6. EUFLEXXA $60 3 payments
  7. Identity $50 1 payment
  8. JOURNAVX $32 2 payments
  9. DYONICS POWERMINI $27 1 payment
  10. DYNOMITE $27 1 payment
  11. Other $98 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

112

Median for Orthopedic Surgery: 203

Drug cost

$406

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methylprednisolone Generic 38 $213
Meloxicam Generic 50 $135
Cephalexin Generic 13 $44
Tramadol Hcl Generic 11 $14

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 68 billing codes

Paid by Medicare

$71,799

Of which drugs: $234

Medicare patients

230

Average age 74

Services billed

1,088

141 women, 89 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 73%
Arthritis 68%
Ischemic heart disease 37%
Diabetes 29%
Depression 21%
Chronic kidney disease 20%
Heart failure 17%
Atrial fibrillation 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 79 325 $234

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ELIQUIS
  • PFIZER INC. $16
$16 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

21 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record